Trials / Completed
CompletedNCT00042432
Study for Secondary Hyperparathyroidism in Chronic Renal Insufficiency Patients
A Study of an Investigational Medication for Secondary Hyperparathyroidism in Chronic Renal Insufficiency Patients
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 54 (actual)
- Sponsor
- Amgen · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study will assess an investigational medication for patients with chronic renal insufficiency (pre-dialysis) who have secondary hyperparathyroidism.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | cinacalcet (AMG 073) | Initially receive 1 tablet of study medication (cinacalcet or placebo) once daily. Possible sequential dose titrations are 30, 60, 90, 120, 180mg cinacalcet or placebo) daily. The titration phase was 12 weeks and the efficacy assessment phase was 6 weeks. |
Timeline
- Start date
- 2002-06-01
- Primary completion
- 2003-03-01
- Completion
- 2003-08-01
- First posted
- 2002-08-01
- Last updated
- 2013-05-13
- Results posted
- 2011-03-01
Source: ClinicalTrials.gov record NCT00042432. Inclusion in this directory is not an endorsement.